Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Patients with type 2 diabetes mellitus are at risk for accelerated cognitive decline and dementia. Furthermore, their risk of stroke is increased and their outcome after stroke is worse than in those without diabetes. Incretin‐based therapies are a class of antidiabetic agents that are of interest in relation to these cerebral complications of diab...
Alternative Titles
Full title
Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4718099
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4718099
Other Identifiers
ISSN
2040-1116
E-ISSN
2040-1124
DOI
10.1111/jdi.12420
